The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Demographic and treatment characteristics for advanced basal cell carcinoma (aBCC) in an oncology outpatient setting.
A. D. Joshi
No relevant relationships to disclose
M. T. Forsyth
No relevant relationships to disclose
D. C. Fryefield
Employment or Leadership Position - US Oncology
W. Lopez
No relevant relationships to disclose
D. M. Chen
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
D. D. Ramanan
Employment or Leadership Position - Genentech
Stock Ownership - Genentech